BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/15/2023 1:46:53 PM | Browse: 265 | Download: 1068
 |
Received |
|
2023-04-19 10:00 |
|
Peer-Review Started |
|
2023-04-19 10:02 |
|
First Decision by Editorial Office Director |
|
2023-06-20 19:21 |
|
Return for Revision |
|
2023-06-20 19:21 |
|
Revised |
|
2023-06-29 16:33 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-07-24 03:03 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-07-29 21:27 |
|
Articles in Press |
|
2023-07-29 21:27 |
|
Edit the Manuscript by Language Editor |
|
2023-10-01 04:25 |
|
Typeset the Manuscript |
|
2023-11-03 08:20 |
|
Publish the Manuscript Online |
|
2023-11-15 13:46 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Dopamine and cyclic adenosine monophosphate-regulated phosphoprotein with an apparent Mr of 32000 promotes colorectal cancer growth
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kuan He, Chao-Zheng Xie, Ya Li, Zhen-Zhou Chen, Shi-Hao Xu, Si-Qi Huang, Jian-Guo Yang, Zheng-Qiang Wei and Xu-Dong Peng |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chongqing Key Diseases Research and Application Demonstration Program |
No. 2019ZX003 |
| General Project of Chongqing Nature Science Foundation |
No. cstc2021jcyj-msxmX0283 |
|
| Corresponding Author |
Xu-Dong Peng, PhD, Doctor, Doctor, Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing 400000, China. 846393577@qq.com |
| Key Words |
Colorectal cancer; Dopamine and cyclic adenosine monophosphate-regulated phosphoprotein with an apparent Mr of 32000; Proliferation; Migration; Phosphoinositide 3-kinase; Akt |
| Core Tip |
Dopamine and cyclic adenosine monophosphate-regulated phosphoprotein with an apparent Mr of 32000 (DARPP-32) is frequently upregulated in colorectal cancer (CRC). Overexpression of DARPP-32 promotes cancer cell proliferation, migration, invasion and reduces apoptosis. Mechanistic investigations reveal that DARPP-32 may exert its oncogenic functions through regulation of the phosphoinositide 3-kinase/AKT signaling pathway which is involved in cell survival and proliferation. These findings indicate that DARPP-32 plays an essential role in facilitating colorectal tumorigenesis and progression. Therefore, DARPP-32 may represent a potential novel biomarker and therapeutic target for CRC treatment. |
| Publish Date |
2023-11-15 13:46 |
| Citation |
He K, Xie CZ, Li Y, Chen ZZ, Xu SH, Huang SQ, Yang JG, Wei ZQ, Peng XD. Dopamine and cyclic adenosine monophosphate-regulated phosphoprotein with an apparent Mr of 32000 promotes colorectal cancer growth. World J Gastrointest Oncol 2023; 15(11): 1936-1950 |
| URL |
https://www.wjgnet.com/1948-5204/full/v15/i11/1936.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v15.i11.1936 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
